Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dr. Reddy's (RDY) to Begin Phase III Study on Sputnik Vaccine

Dr. Reddy's (RDY) receives approval from the DCGI to conduct a phase III study on the Sputnik V vaccine for the treatment of COVID-19 in India.

AZN : 51.34 (+0.10%)
RDY : 71.06 (-1.32%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know

Moderna (MRNA) closed at $124.06 in the latest trading session, marking a -0.39% move from the prior day.

MRNA : 129.65 (-0.05%)
Stock Market News for Jan 13, 2021

Benchmarks closed in the positive territory on Tuesday as investors remained optimistic on possible fiscal stimulus and vaccine roll out.

JPM : 138.64 (-1.79%)
TRV : 143.24 (+0.65%)
GS : 301.01 (-2.23%)
BAC : 33.01 (-2.88%)
INTC : 57.58 (-2.82%)
BIDU : 238.87 (-4.07%)
MRNA : 129.65 (-0.05%)
DOCU : 249.28 (-0.39%)
Thinking about trading options or stock in Nio, Ford Motor, Johnson & Johnson, Moderna, or General Motors?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NIO, F, JNJ, MRNA, and GM.

MRNA : 129.65 (-0.05%)
F : 9.83 (-3.34%)
GM : 49.97 (-3.03%)
JNJ : 160.30 (-0.22%)
NIO : 56.27 (-7.56%)
Flat Session Gets Market Back in the Green

Flat Session Gets Market Back in the Green

DNOW : 8.88 (-3.79%)
RYAM : 7.38 (-3.15%)
SQQQ : 15.32 (+2.41%)
MHK : 148.97 (-1.97%)
OSTK : 59.52 (-7.10%)
GS : 301.01 (-2.23%)
MU : 80.72 (-0.71%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
NVAX : 127.43 (-1.96%)
JPM : 138.64 (-1.79%)
C : 64.23 (-6.93%)
WFC : 32.04 (-7.80%)
PNC : 154.78 (-4.16%)
Markets Prove Buoyant; KB Home (KNH) Beats Q4 Estimates

KB Home's $1.12 per share was well out in front of the 87 cents in the Zacks consensus, while revenues of $1.19 billion topped the $1.11 billion expected.

MRNA : 129.65 (-0.05%)
KBH : 35.76 (+1.33%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
LLY : 190.77 (+2.19%)
IBB : 161.71 (-0.10%)
CNCR : 34.65 (-1.00%)
XBI : 151.73 (-1.11%)
BBH : 180.97 (+0.53%)
FBT : 176.29 (+0.05%)
SBIO : 56.23 (-1.00%)
PBE : 76.14 (-0.12%)
BTEC : 63.68 (-0.75%)
ARKG : 107.96 (-1.23%)
BNTX : 101.59 (-4.02%)
COVID-19 Vaccine Production to Ramp Up

COVID-19 Vaccine Production to Ramp Up

PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
BNTX : 101.59 (-4.02%)
Covid-19 Vaccinations Promise to Ramp Up

Guidance for the end of 2020 was to have 20 million Americans with the first half of the two-injection immunization treatment; as of now, only around 9 million Americans have received the first dose.

PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
BNTX : 101.59 (-4.02%)
Moderna (MRNA) Stock Up on Vaccine Pipeline Expansion Plan

Moderna (MRNA) plans to initiate clinical studies on new candidates as potential vaccine for seasonal flu, HIV and the Nipah virus.

JNJ : 160.30 (-0.22%)
AZN : 51.34 (+0.10%)
MRNA : 129.65 (-0.05%)
BNTX : 101.59 (-4.02%)
Jose M. Vega, M.D. Joins Moderna as Chief Safety Officer

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Jose M. Vega, M.D. joined Moderna as Chief Safety Officer effective...

MRNA : 129.65 (-0.05%)
MRK : 83.38 (+1.47%)
AMGN : 245.49 (+1.58%)
Uber and Moderna Collaborate to Raise Awareness and Increase Access to COVID-19 Vaccines

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Uber Technologies, Inc. (NYSE: UBER), the world's leading ridesharing and delivery platform,...

MRNA : 129.65 (-0.05%)
UBER : 55.52 (-2.44%)
Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has authorized...

MRNA : 129.65 (-0.05%)
4 Reasons for Bank ETFs to Win in 2021

Bank ETFs should stay strong in the coming days on the back of cheaper valuation, Fed's signal for buybacks, Democrat's control over Senate and spike in bond yields.

AZN : 51.34 (+0.10%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
KBE : 46.04 (-2.17%)
IAT : 49.86 (-2.20%)
FTXO : 26.69 (-2.42%)
KBWB : 55.02 (-3.22%)
Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day

Infrastructure and Energy Alternatives, Carrols Restaurant, Moderna, Blueprint Medicines and Halozyme Therapeutics highlighted as Zacks Bull and Bear of the Day

MRNA : 129.65 (-0.05%)
HALO : 47.43 (+0.81%)
TAST : 6.88 (+0.73%)
BPMC : 100.99 (-1.48%)
IEA : 21.43 (-4.37%)
Futures Down as Investors Weigh Covid-19 Cases Against Vaccines

Futures Down as Investors Weigh Covid-19 Cases Against Vaccines

JNJ : 160.30 (-0.22%)
AZN : 51.34 (+0.10%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
Racing Against Time: Covid-19 vs. Vaccines

This past Friday brought the U.S. its largest single-day amount of Covid-19 cases since the pandemic began in earnest back in March of last year: 310K in a single 24-hour period.

JNJ : 160.30 (-0.22%)
AZN : 51.34 (+0.10%)
PFE : 36.70 (-0.14%)
MRNA : 129.65 (-0.05%)
Health Officials Warn Of COVID-19 Vaccine Shortages Across Canada

Health authorities across Canada are warning that they’re running low on COVID-19 vaccines. The ...

PFE : 36.70 (-0.14%)
BNTX : 101.59 (-4.02%)
MRNA : 129.65 (-0.05%)
GSK : 38.47 (+0.81%)
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines

--HIV vaccine program to accelerate human validation of novel vaccination strategies

MRNA : 129.65 (-0.05%)
AMGN : 245.49 (+1.58%)
SNY : 49.39 (+0.73%)
PFE : 36.70 (-0.14%)
GSK : 38.47 (+0.81%)
Thinking about trading options or stock in Baidu, Moderna, Micron Technology, Riot Blockchain, or New Relic?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BIDU, MRNA, MU, RIOT, and NEWR.

MU : 80.72 (-0.71%)
BIDU : 238.87 (-4.07%)
MRNA : 129.65 (-0.05%)
RIOT : 25.78 (-10.80%)
NEWR : 75.87 (-1.22%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar